Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Announcing CHI's Mastering Risk-Based Monitoring Conference, May 9-10, 2016, BostonProactively building quality standards and risk management into the design and planning of clinical trials.
Confirmed Presentations: CASE STUDY: A Practical Guide to Successful RBM Implementation Stacy Foley, Project Director, Global Risk-Based Monitoring Implementation, Merck Co-Presentation: Kate Owen, Vice President, Clinical Trial Management, Novo Nordisk Heather Achenbach, Senior Director, Clinical Trial Management, Novo Nordisk Lessons I Wish Someone Had Told Me: Risk-Based Monitoring Implementation Challenges Sheryl Jacobs, Vice President, Global Study Operations, Amgen A Next-Generation Platform for Clinical Data Integration and Risk-Based Monitoring: Why Data and User Centricity Matters Dimitris Agrafiotis, Ph.D., Vice President, Chief Data Office & Head, Technology Products, Covance Inc. Sponsored by: Covance Inc. Presentation to be announced Sponsored by: Medidata Co-Presentation: Mary Cusack, Associate Director, Bristol-Myers Squibb Ed Kellar, Director, Global Data Management Operational Support, Astellas, Inc. Establishing a Quality Management System (QMS) David Nickerson, Senior Director, Portfolio & Vendor Quality, Pfizer Co-Presentation: Brian Nugent, Associate Director, PALM, Clinical Operations, Gilead Sciences Angie Maurer, RN, BSN, MBA, Clinical Operations Consultant, PALM/Clinical Operations, Gilead Sciences Optimizing Risk and Quality in Managing Observational Research Hady Khoury, Vice President, Global Head, Research & Alliance Services, Peri-Approval & Observational Research, Commercialization & Outcome, ICON plc Sponsored by: ICON plc Co-Presentation: Andy Lawton, Global Head, Data Management, Biometrics & Data Management, Boehringer Ingelheim Ltd. Jean Baumann, Change Management Specialist, JMB Consulting, LLC Presentation to be Announced Speaker to be Announced, Remarque Systems, Inc. Writers and editors are invited to attend. To request a press pass, email Lisa Scimemi, lscimemi@healthtech.com. For details on sponsorship, exhibit and lead generation packages, contact Ilana Quigley, Tel: 781-972-5457, iquigley@healthtech.com. For more information, visit http://www.clinicaltrialsummit.com/ About Clinical Trial Oversight Summit Cambridge Healthtech Institute's Fifth Annual Clinical Trial Innovation Summit will bring together leaders from across pharma, biotech and academia to share case studies and best practices on effective clinical trial management and vendor oversight. The 2016 program focuses on key issues and opportunities in the clinical trial industry, including patient recruitment, site selection, data integration, mobile technologies, project management, outsourcing, budgeting, quality in trial conduct, risk-based monitoring and auditing. About Cambridge Healthtech Institute (CHI) Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Pharmaceutical Congress, Next Generation Dx Summit and Discovery on Target. CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Knowledge Foundation Bio-IT World Clinical Informatics News and Diagnostics World. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|